Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer.
Alexandra von AuSamra ShencoruLorenz UhlmannLuisa MayerLaura MichelMarkus WallwienerAndré HennigsThomas DeutschFabian RiedelJoerg HeilMichael GolattaAndreas SchneeweissFlorian SchützChristoph DomschkePublished in: Archives of gynecology and obstetrics (2022)
NLR was significantly higher only for patients achieving pCR in the Luminal B/Her2-negative and postmenopausal subgroups. Hence, NLR is a candidate additional predictive factor in patients with Luminal B/Her2-negative BC.